Outcomes and costs of primary care surveillance and intervention for overweight or obese children: the LEAP 2 randomised controlled trialBMJ 2009; 339 doi: https://doi.org/10.1136/bmj.b3308 (Published 03 September 2009) Cite this as: BMJ 2009;339:b3308
- Melissa Wake, paediatrician1,
- Louise A Baur, professor2,
- Bibi Gerner, research officer1,
- Kay Gibbons, head of Nutrition and Food Services1,
- Lisa Gold, health economist4,
- Jane Gunn, professor3,
- Penny Levickis, research assistant1,
- Zoë McCallum, paediatrician1,
- Geraldine Naughton, director5,
- Lena Sanci, research fellow3,
- Obioha C Ukoumunne, statistician1
- 1Royal Children’s Hospital, Murdoch Childrens Research Institute and University of Melbourne, Parkville, Vic 3052, Australia
- 2Discipline of Paediatrics and Child Health, University of Sydney and the Children’s Hospital at Westmead, Westmead, NSW 2145, Sydney, Australia
- 3Department of General Practice, University of Melbourne
- 4Health Economics Unit, School of Health and Social Development, Deakin University, Burwood, Vic 3125, Australia
- 5Centre of Physical Activity Across the Lifespan, School of Exercise Science, Australian Catholic University, Strathfield NSW 2135, Australia
- Correspondence to: M Wake, Centre for Community Child Health, Royal Children’s Hospital, Flemington Rd, Parkville, Vic 3052, Australia
- Accepted 14 April 2009
Objective To determine whether ascertainment of childhood obesity by surveillance followed by structured secondary prevention in primary care improved outcomes in overweight or mildly obese children.
Design Randomised controlled trial nested within a baseline cross sectional survey of body mass index (BMI). Randomisation and outcomes measurement, but not participants, were blinded to group assignment.
Setting 45 family practices (66 general practitioners) in Melbourne, Australia.
Participants 3958 children visiting their general practitioner in May 2005-July 2006 were surveyed for BMI. Of these, 258 children aged 5 years 0 months up to their 10th birthday who were overweight or obese by International Obesity Taskforce criteria were randomised to intervention (n=139) or control (n=119) groups. Children who were very obese (UK BMI z score ≥3.0) were excluded.
Intervention Four standard consultations over 12 weeks targeting change in nutrition, physical activity, and sedentary behaviour, supported by purpose designed family materials.
Main outcomes measures Primary measure was BMI at 6 and 12 months after randomisation. Secondary measures were mean activity count/min by 7-day accelerometry, nutrition score from 4-day abbreviated food frequency diary, and child health related quality of life. Differences were adjusted for socioeconomic status, age, sex, and baseline BMI.
Results Of 781 eligible children, 258 (33%) entered the trial; attrition was 3.1% at 6 months and 6.2% at 12 months. Adjusted mean differences (intervention − control) at 6 and 12 months were, for BMI, −0.12 (95% CI −0.40 to 0.15, P=0.4) and −0.11 (−0.45 to 0.22, P=0.5); for physical activity in counts/min, 24 (−4 to 52, P=0.09) and 11 (−26 to 49, P=0.6); and, for nutrition score, 0.2 (−0.03 to 0.4, P=0.1) and 0.1 (−0.1 to 0.4, P=0.2). There was no evidence of harm to the child. Costs to the healthcare system were significantly higher in the intervention arm.
Conclusions Primary care screening followed by brief counselling did not improve BMI, physical activity, or nutrition in overweight or mildly obese 5-10 year olds, and it would be very costly if universally implemented. These findings are at odds with national policies in countries including the US, UK, and Australia.
Trial registration ISRCTN 52511065 (www.isrctn.org)
Childhood obesity is now endemic in many countries.1 2 The long term physical, emotional, social, reproductive, and economic ramifications are likely to be immense. While prevention and intervention are expected to be needed throughout life for much of the population, effective strategies during childhood may best minimise psychosocial and physical morbidity. 3 4 However, because of the sheer scale of the problem, tackling childhood obesity in the secondary or tertiary health care sector is not feasible for any but those who are most severely affected.
Primary care physicians, such as general practitioners (GPs), seem ideally placed to take on this issue because in many countries they are the only source of primary health care accessible to families across most of the social spectrum. GPs experience barriers in tackling childhood obesity, yet see it as extremely important and are optimistic that they can make a difference.5 6 National policies in countries including the United Kingdom,7 United States,8 and Australia9 currently endorse the GP or family physician as central to surveillance for childhood overweight and obesity and counselling.
Evidence supporting such an approach in primary care, however, is conspicuously lacking.10 Despite high political appeal, two recent systematic reviews could not recommend screening because of the poor sensitivity and specificity of body mass index (BMI) cut points, lack of management strategies with demonstrated efficacy, and lack of evidence that benefits outweigh the harms.11 12 We could locate two trials (one randomised,13 one non-randomised14) in which a brief primary care intervention was offered to young children whose overweight/obese status was ascertained through office surveillance; neither was effective in reducing BMI relative to controls. However, both were hampered by small sample sizes, and, given the clear policy imperatives to locate childhood obesity management in primary care, further research is clearly warranted.
This paper reports 12 month outcomes from the LEAP2 randomised controlled trial. Its primary aim was to reduce BMI gain in overweight or mildly obese 5-10 year old children identified through surveillance in primary care. Secondary aims were to increase physical activity and improve child nutrition, to quantify any harms experienced by the child, and to compare the costs and consequences of the intervention from a health sector perspective.
Study design and setting
A randomised controlled trial was nested within a large, cross sectional survey of BMI in family practices in Melbourne (population 3.7 million), Australia.
General practitioner recruitment and education
A non-representative sample of 66 general practitioners in 45 family medical practices was recruited by personalised letters sent to 1709 GPs via a paediatric special interest group spanning 11 Melbourne divisions of general practice, the Health Insurance Commission, GPs from the LEAP1 trial, and contacts made through these networks; the letter was followed by recruitment evenings and practice visits. GPs attended two 2½ hour group training sessions for instruction in the “stages of change” model15 and training in brief, solution focused, family therapy.16 They received a 30 minute DVD, developed for the trial, showing role model scenarios of GPs using solution focused therapy in consultations for healthy family lifestyle.
Each GP then conducted two simulated patient sessions (an “initial LEAP2 consultation” of 30 minutes, and a “follow-up consultation” of 20 minutes) during standard working hours supported by a mock patient file and materials. These visits mimicked the forthcoming intervention consultations, except that a child did not attend with the actor portraying the parent. After each consultation, the actor evaluated the GP’s performance on 10 items, gave feedback to the GP, and communicated a summed “global score” (out of 10) via text message to the research team. GPs were paid $A100 per simulated patient consultation. The two GPs who were given a global score ≤5 for the second visit were offered an extra set of visits; one withdrew, while the other received higher scores and continued his involvement.
All children aged 5 years 0 months up to their 10th birthday attending participating practices for any reason during May 2005 to July 2006 were eligible to be invited into the BMI survey by practice staff. Researchers also ran one or two dedicated measuring sessions in each of the larger practices, to which parents of all suitably aged children registered with the practice were invited by letter. Children in the survey were eligible for the trial if they were not receiving an ongoing weight management programme and were overweight or obese according to the cut-off points of the International Obesity Taskforce.17 Children were excluded if their BMI z score was ≥3.0 (transformed using the LMS method18 and the 1990 UK Growth Reference19), on the basis that a brief secondary prevention approach was inappropriate. The research team then mailed an informed consent form and baseline questionnaire to interested parents with eligible children, and randomisation occurred once the completed forms were received by the research team. Follow-up was as close as possible to six and 12 months after randomisation, which equated to a mean of 9.0 months (SD 1.1) and 15.2 months (SD 1.2) from the baseline measurements. Thus, recruitment occurred in May 2005-July 2006, intervention delivery in October 2005-December 2006, the first follow-up in April 2006-March 2007, and the second follow-up in October 2006-September 2007.
Randomisation by child was stratified by GP and by overweight versus obese status; it was performed by an independent biostatistician using computer generated random numbers. The randomisation sequence was concealed from the study investigators, and the researchers collecting data remained blind to participants’ trial status until follow-up was complete. Intervention families were notified by the non-blinded member of the research team (BG) and assisted in making the first doctor’s appointment. Control families were notified via letter; general practice records of control children were subsequently audited to assess possible contamination (that is, attendances for discussion of weight). General practitioners knew the assignment status of any of their children who were in the intervention group, but did not otherwise know who among their large client base was enrolled in the survey or trial, so were generally unaware of control group membership.
The intervention had the same components as in the LEAP1 trial,20 designed using an intervention mapping technique within a behavioural epidemiology framework. GPs used a brief, solution focused approach21 to set and record appropriate, healthy lifestyle goals, assisted by a 16 page “family folder” written at a 12 year old reading level to be sure that virtually all parents could understand it. This folder included five topic sheets, each targeting one area of behavioural change (sedentary time, physical activity, water consumption, family eating habits, and lower fat options for food). Each sheet summarised supporting evidence, modelled solutions to challenges, and made suggestions as to how each goal might be reached.
Before the first appointment, the GP received the child’s named intervention materials, BMI, and a two page summary of parent responses from the baseline questionnaire regarding current nutrition, physical activity patterns, and concern regarding their child’s weight status. Parents were offered four consultations over a 12 week period. Visit date, content discussed, and contracts made were recorded on a LEAP2 form in the child’s medical record. If any “non-LEAP2” visits occurred, the GP was asked to reinforce any LEAP2 strategies previously discussed.
Follow-up data were collected via written parent questionnaire (at baseline and six and 12 months after randomisation), child questionnaire (at six and 12 months), anthropometric measurement (baseline and six and 12 months), and accelerometry measurement (six and 12 months). The primary outcome measure was BMI (weight (kg)/(height (m)2)). Weight was measured in light clothing to the nearest 100 g using digital scales (Tanita, Japan, ModelTHD-646) and height was measured (twice) to the nearest 0.1 cm using a portable rigid stadiometer (Invicta, Oadby, Leicester, Model IPO955). The average of the height measurements was used in analyses; if the two differed by ≥0.5 cm a third measurement was taken and the mean of the closest two values was used. BMI z score was also calculated using the US Centers for Disease Control (CDC) 2000 sex-specific BMI-for-age growth charts.22
Secondary outcome measures are shown in table 1⇓. Socioeconomic status, a potential prognostic factor, was quantified using the Australian census based Index of Relative Socio-economic Disadvantage score for the participant’s home postal code (mean score for Victoria 1020.3 (SD 59.4)).23 Costs were evaluated from a healthcare perspective and calculated in Australian dollars ($A) at 2007 costs. Resources required to provide the LEAP2 intervention were recorded by the research team and via an audit of GP visits for intervention and control families. Resource use was valued using appropriate salary scales, travel cost allowances, and fee rates from the Medicare Benefits Schedule.24
We aimed to reduce the expected increase in BMI from 0.8 to ≤0.5 over 12 months. In the LEAP1 trial, the standard deviation of BMI values was 2.2 at both baseline and at 12 months after randomisation, and the correlation between the baseline and 12 month values was 0.88. Using these values, we calculated that 190 overweight or mildly obese children in each group would ensure 80% power at the 5% level of significance (two sided) to detect a reduction in mean BMI increase as small as 0.3 units.
We used Stata 9.2 software.25 Participants were analysed in the groups to which they were randomised. Linear and logistic regression models (for quantitative and dichotomous outcomes respectively) were fitted for unadjusted and adjusted models. In the latter, all comparisons were adjusted for socioeconomic disadvantage,23 age at randomisation, sex, and baseline score for the outcome (where collected). All analyses except BMI z score were also adjusted for raw BMI at baseline.
For some outcomes, each subject accrued several scores (that is, the 48 scores for parents’ reports of their child’s physical activity and four scores for child’s nutrition—see table 1⇑). For these measures, random effects (“multilevel”) models using maximum likelihood estimation26 for quantitative outcomes, and marginal models using generalised estimating equations27 for dichotomous outcomes, were fitted for the regression analyses to allow for within-subject correlation. The six dichotomous items on physical appearance and global self worth (see table 1) were analysed as a multivariate outcome, again using the generalised estimating equations method for logistic regression to allow for within-subject correlations.
Sensitivity analyses that additionally allowed for correlation between children seen by the same general practitioner provided essentially the same results as the main analyses, so we report only the latter here. Because some quantitative outcomes were non-symmetrical, results were validated using bias-corrected accelerated bootstrap confidence intervals.28
Table 2⇓ reports baseline characteristics of the children, which were similar in the two trial arms. The location of participating practices covered the sociodemographic spectrum, with the median practice close to the 50th centile (range from <10th to >90th centile) on the Index of Relative Socio-economic Disadvantage.23
The figure⇓ shows the participant flow throughout the trial: 139 and 119 participants were allocated to the intervention and control arms, respectively. Overall attrition rates for anthropometry data collection was 3.1% (250) at six months and 6.2% (242) at 12 months. Completion rates at six and 12 months, respectively, for questionnaires were 97.3% (251) and 91.9% (237); 89.5% (231) and 77.9% (201) for useable accelerometry data; and 93.8% (242) and 88.4% (228) for 4 day food and nutrition diaries.
Primary outcome (body mass index)
Tables 3⇓ and 4⇓ show unadjusted and adjusted outcome comparisons between the intervention and control arms at six months and 12 months after randomisation respectively. At six months, the adjusted mean BMI of the intervention group was 0.12 lower than that of the control group (adjusted mean difference −0.12 (95% CI −0.40 to 0.15, P=0.38), and, at 12 months, the adjusted mean BMI was 0.11 lower (adjusted mean difference −0.11 (−0.45 to 0.22, P=0.51). Mean BMI z score (not shown) and waist circumference were similar in the two trial arms.
Overall physical activity, as measured by accelerometry, was slightly but not significantly higher in the intervention than control group at six months (mean difference 24 counts/min (95% CI −4 to 52, P=0.09)) and at 12 months (mean difference 11 counts/min (−26 to 49, P=0.55)). Similarly, overall nutrition scores were only marginally better in the intervention group (mean difference at six months 0.2 (95% CI −0.03 to 0.4, P=0.10); at 12 months 0.1 (−0.1 to 0.4, P=0.24)). Parents reported lower consumption of soft drinks in the intervention group at both time points, but no marked differences in fruit, vegetable, fat, or water consumption.
There was no evidence that the intervention was harmful as perceived by the children, whose reports of health related quality of life, body dissatisfaction, and self esteem were similar to those of control children. Compared with control parents, however, parents in the intervention group reported improved child health related quality of life at six months (mean difference 3.1 points higher (95% CI 0.6 to 5.7, P=0.02)) and at 12 months (3.1 points higher (0.2 to 6.0, P=0.03)), which was evident for both the physical and psychosocial summary scores.
All GPs attended at least one of the GP education sessions—65 (98.5%) attended the first, and 64 (97%) attended the second—and all completed the two simulated patient consultations.
Fifty one (37%) of the 139 children in the intervention arm attended all four of the intervention consultations, 31 (22%) attended three, 29 (21%) attended two, 16 (12%) attended one, and 12 (9%) attended none. Intervention families had a mean of 2.7 LEAP2 consultations. During the 12 months after allocation, intervention and control children both had a mean of 0.9 incidental visits to their LEAP2 GP, and incidental visits to a non-LEAP2 GP were also similar (1.4 for the intervention children and 1.6 for the controls). The general practice record audit indicated minimal contamination among the control children: five were weighed and/or measured by their LEAP2 GP during these visits, but there was no indication in their records that weight or weight management was discussed.
Health sector costs
The cost to the health sector of providing the LEAP2 intervention (BMI surveillance, GP recruitment and training) to the 66 participating GPs was $A152 000. Including the costs of all GP consultations with participating families, costs borne by the health sector were $A1317 per intervention child and $A81 per control, a difference of $A1236 (95% CI $A1205 to $A1267). It should be noted that the GPs in the LEAP2 trial provided the intervention to an artificially small number of children (2.1 per GP). These costs would fall if the intervention were provided to a greater number of children per GP—for example, to $A412 (95% CI $A381 to $A442) if each GP managed 30 children. This still, however, represents a marked increase in costs for no real improvement in the primary or secondary outcomes.
Although we aimed for 190 children in each arm of this trial, only 127 remained in the intervention arm and 115 in the control arm at 12 months. This meant that the smallest difference in BMI between the trial arms that could be detected with 80% power was 0.38, rather than the desired 0.30. However, the similarity of design and content provided an opportunity to combine the results from both LEAP trials in a meta-analysis. With a combined total of 196 subjects in the intervention arm and 191 subjects in the control arm at 12 months, the smallest BMI difference detectable with 80% power was 0.30. A fixed effects meta-analysis of combined LEAP2 and LEAP1 data showed that the adjusted mean BMI difference at six months was −0.16 (95% CI −0.38 to 0.06) and at 12 months was −0.06 (−0.34 to 0.22). Thus, although a mean improvement in the intervention arm as large as 0.3-0.4 is possible, the body of evidence points towards no important difference between the trial arms.
Post hoc analyses
Since national policies often use the proportion overweight, rather than mean BMI, as the target for assessing effective intervention, we also examined outcomes according to dichotomised BMI (that is, overweight/obese versus not overweight/obese) using the International Obesity Taskforce cut points. At 12 months, 77.2% of the LEAP2 intervention children remained overweight/obese compared with 82.6% of the controls (difference −5.4% (95% CI −15.5% to 4.6%, P=0.29)). Similar values were obtained in the meta-analysis (80.2% v 84.8%; difference −4.6% (−12.2% to 2.9%, P=0.23)).
There was no evidence at the 5% level in adjusted models that socioeconomic status (using scores from the disadvantage index) modified the effect of the intervention on the main outcomes of BMI, activity, or nutrition at six or 12 months. Similarly, there was no strong evidence that attending more consultations improved BMI at six months (P=0.18) or at 12 months (P=0.60) after adjustment for baseline BMI.
This trial suggests that current international policy directions for primary care surveillance and brief counselling are unlikely to be effective in reducing childhood obesity. Neither the primary outcome (BMI) nor key secondary outcomes (physical activity, nutrition, parental BMI) showed marked improvement. Although there was no evidence that the child experienced physical or psychosocial harm as a result of the intervention, a significant investment of healthcare resources was incurred that could be used to greater effect elsewhere.
Strengths and limitations of study
Strengths of the study include its randomised design, the objective measures of anthropometry and physical activity, the strong uptake by families and GP practices spanning the range of socioeconomic status, follow-up for a full year, and the extremely high retention rate. Because of the large sample size, the confidence intervals were sufficiently narrow to conclude that any benefit to BMI trajectory was not clinically important. There was no evidence that contamination explains the null findings. Though we could not be sure that GPs implemented the intervention as intended, GPs could only proceed to LEAP families once the two simulated patient visits had been delivered satisfactorily.
Limitations include the select volunteer nature of the participating GPs, but it seems unlikely that less committed or interested GPs would achieve a better result. Only a third of the families with a child identified as eligible chose to take up the intervention; again, it seems unlikely that those who were not recruited to the trial would have fared better, and this would be a problem at the public health level only had the intervention been effective. It was not possible to blind the families to group membership, but this limitation would typically be expected to increase, not reduce, between-group differences on self reported measures.
Interpretation in light of other studies
These negative findings are congruent with two smaller trials of brief, individualised primary care approaches targeting overweight or mildly obese children identified by screening.13 14 Therefore, the most likely interpretation is that such interventions are ineffective in reducing BMI. This could be due to insufficient intervention intensity or duration; in recent studies in tertiary obesity clinics, sustained BMI reduction occurred only when interventions occurred over 9-12 months.29 30 Interventions in this BMI range might be more effective when initiated by families seeking help rather than via a screening process. However, this would be unlikely to address the public health issue adequately, as only a minority are sufficiently concerned to seek help for their overweight children, and individual effects have uniformly been modest31 32 or absent.33
Conclusions and policy implications
This brief, physician led, primary care intervention produced no long term improvement in children’s BMI, physical activity, or nutrition. These findings cast doubt on many countries’ current policies that support universal surveillance coupled with brief, individualised secondary prevention by the primary care sector to reduce childhood obesity. Thus far, each new study has progressively added weight to the view that overweight and mild obesity in primary school children do not meet criteria for the introduction of screening programmes.12 Resources may be better divided between primary prevention at the community and population levels, and enhancement of clinical treatment options for children with established obesity.
What is already known on this subject
With around 25% of all children worldwide now overweight or obese, hospital services cannot hope to provide adequate weight management services
National policies in many countries (including the US, UK, and Australia) promote primary care surveillance and brief counselling to reduce childhood obesity
Two systematic reviews have highlighted that there is no evidence to support this approach
What this study adds
Primary care screening followed by brief counselling did not improve body mass index, physical activity, or nutrition in overweight or mildly obese 5-10 year olds, and the approach would be very costly if universally implemented
These findings are at odds with current national policies
Resources may be better spent on primary prevention strategies at the community and population levels, and on enhancing treatment options
Cite this as: BMJ 2009;339:b3308
Contributors: The project was initiated and supervised by MW, JG, LAB, ZM, and KG, who also obtained its funding. All authors contributed to developing the protocols and reviewing, editing, and approving the final version of the paper. The trial was implemented by MW, ZM, and BG, who oversaw all stages. BG and PL carried out recruitment and data collection, with other field workers. LS, Colin Riess, and Helen Cahill contributed medical education planning, implementation, and expertise. Lucy Rogers and Rachel Barratt contributed to recruitment, retention, and data collection from families and general practitioners. OCU conducted the analyses, with the exception of the economic analysis, which was performed by LG. MW and BG wrote the paper, with critical input from the other authors. MW is the guarantor. We thank Colin Riess, Helen Cahill, Lucy Rogers, and Rachel Barratt for their contributions to the project.
Funding: This study was funded by the Australian National Health and Medical Research Council (NH&MRC) Project Grant 334309. MW is supported by NH&MRC Career Development Award 284556; LG by NH&MRC Capacity Building Grant 425855; and OCU by NH&MRC Capacity Building Grant 436914. The researchers were independent of the funders.
Competing interests: None declared.
Ethical approval: The project was approved by the Royal Children’s Hospital Ethics in Human Research Committee (EHRC 25006).
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.